This site is intended for healthcare professionals

Athenex announces FDA approval of Klisyri for the treatment of actinic keratosis on the face or scalp.

Read time: 1 mins
Last updated:28th Jun 2021
Published:28th Dec 2020
Condition: Actinic Keratosis
Type: drug
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest